SOUTHWEST ONCOLOGY GROUP

西南肿瘤集团

• 批准号: 6626678
• 负责人: Glenn M Mills
• 金额: $ 31.43万
• 依托单位: LOUISIANA STATE UNIV HSC SHREVEPORT
• 依托单位国家: 美国
• 财政年份: 1993
• 资助国家: 美国
• 起止时间: 1993-04-01 至 2003-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6626678
• 关键词: antineoplastics; bleomycin; bone marrow transplantation; brain neoplasms; breast neoplasms; cancer information system; cancer prevention; cancer registry /resource; cis platinum compound; clinical research; clinical trials; combination cancer therapy; combination chemotherapy; cooperative study; cyclophosphamide; doxorubicin; drug resistance; female reproductive system neoplasm; fludarabine; gastrointestinal neoplasms; head /neck neoplasm; hormone therapy; human subject; human therapy evaluation; ifosfamide; leukemia; lung neoplasms; lymphoma; meeting /conference /symposium; melanoma; multiple myeloma; neoplasm /cancer chemotherapy; neoplasm /cancer diagnosis; neoplasm /cancer epidemiology; neoplasm /cancer genetics; neoplasm /cancer immunotherapy; neoplasm /cancer radiation therapy; neoplasm /cancer surgery; oncology nursing; paclitaxel; pancreas neoplasms; pathology; prognosis; prostate neoplasms; quality of life; sarcoma; tamoxifen; tissue resource /registry; urinary tract neoplasms; women's health

Description: LSUMC-S has been a member of SWOG since 1982 and has had funding since 1993. After a period of time with relatively low accrual to protocols, accrual has recently markedly increased and currently is about 180/year and ranks within the top six institutions. LSUMC-S accounts for nearly 12 percent of all minority patients accrued to SWOG studies. Forty-seven percent of all patients placed on SWOG protocols from LSUMC-S are minority. LSUMC-S has four primary sites for patient accrual to studies. These include the University Hospital, the Overton Brooks VAMC, the Willis Knighton Medical Center and the E. A. Conway Hospital. Three CGOP sites are present--St. Francis Hospital, Monroe, Louisiana; Highland Hospital, Shreveport and Baptist Medical Center in New Orleans, Louisiana.

描述：LSUMC-S自1982年以来一直是Swog的成员 自1993年以来的资金。一段时间后，应计的相对较低 协议，应计量明显增加，目前即将 180/年，排名前六名。 LSUMC-S帐户 在所有少数族裔患者中，近12％的患者累积了研究。 所有患者中有47％的患者遵守了LSUMC-S的劳资方案 是少数。 LSUMC-S有四个主要的部位，用于研究患者。 这些 包括大学医院，Overton Brooks VAMC，Willis Knighton医疗中心和E. A. Conway医院。 三个CGOP站点是 现在 - 路易斯安那州门罗弗朗西斯医院；高地医院 路易斯安那州新奥尔良的什里夫波特和浸信会医疗中心。

项目成果

Phase II evaluation of ifosfamide/mesna in metastatic prostate cancer. A Southwest Oncology Group study.

异环磷酰胺/美司钠治疗转移性前列腺癌的 II 期评估。

• DOI: 10.1097/00000421-199608000-00009
• 发表时间: 1996
• 期刊: American journal of clinical oncology
• 作者: Williamson,SK;Wolf,MK;Eisenberger,MA;O'Rourke,MA;Brannon,W;Crawford,ED
• 通讯作者: Crawford,ED